NasdaqCM - Nasdaq Real Time Price USD
CERo Therapeutics Holdings, Inc. (CERO)
0.4545
+0.0265
+(6.19%)
At close: June 6 at 4:00:01 PM EDT
0.4100
-0.04
(-9.79%)
Pre-Market: 7:21:19 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 25,932,018 | 4 |
| Sales | 13,398,100 | 4 |
| Net Shares Purchased (Sold) | 12,533,918 | 8 |
| Total Insider Shares Held | 854.83k | -- |
| % Net Shares Purchased (Sold) | -107.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ATWOOD BRIAN G Director | Conversion of Exercise of derivative security at price 0.00 per share. | Indirect | 29 | Mar 31, 2025 |
| YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.06 - 0.08 per share. | Indirect | 400,456 | Dec 13, 2024 |
| YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.09 - 0.12 per share. | Indirect | 383,370 | Dec 10, 2024 |
| YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.10 per share. | Indirect | 325,000 | Oct 10, 2024 |
| SLOAN STUART M Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.10 per share. | Indirect | 55,538 | Sep 25, 2024 |
| LAPORTE KATHLEEN D Director | -- | Indirect | -- | Sep 25, 2024 |
| ATWOOD BRIAN G Director | -- | Indirect | -- | Sep 25, 2024 |
| EHRLICH CHRISTOPHER B Chief Executive Officer | -- | Direct | -- | Sep 25, 2024 |
Related Tickers
CDT Conduit Pharmaceuticals Inc.
2.6900
-0.37%
PCSA Processa Pharmaceuticals, Inc.
0.3006
+3.55%
SILO Silo Pharma, Inc.
0.5811
-9.20%
GLYC GlycoMimetics, Inc.
0.1938
-2.42%
TOVX Theriva Biologics, Inc.
0.4700
-0.21%
KAPA Kairos Pharma, Ltd.
0.4730
-5.87%
ADTX Aditxt, Inc.
1.5400
+6.94%
PSTV Plus Therapeutics, Inc.
0.3255
+2.04%
REVB Revelation Biosciences, Inc.
0.8594
+5.45%
PHIO Phio Pharmaceuticals Corp.
2.9600
+20.33%